Cite
HARVARD Citation
Kudo, K. et al. (2019). Cell surface CD63 increased by up‐regulated polylactosamine modification sensitizes human melanoma cells to the BRAF inhibitor PLX4032. FASEB journal. 33 (3), pp. 3851-3869. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kudo, K. et al. (2019). Cell surface CD63 increased by up‐regulated polylactosamine modification sensitizes human melanoma cells to the BRAF inhibitor PLX4032. FASEB journal. 33 (3), pp. 3851-3869. [Online].